July 9 (Reuters) - Walvax Biotechnology Co Ltd:
* SHENZHEN STOCK EXCHANGE FILING SHOWS BLOCK TRADE OF WALVAX BIOTECHNOLOGY'S 64.2 MILLION SHARES INVOLVING 1.1 BILLION YUAN ($166.25 million) ON JULY 9 Source text in Chinese: https://bit.ly/2lSW4T8 Further company coverage: ($1 = 6.6165 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
The $50 million purchase could turn into Nvidia's biggest investment.
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
These proven wealth builders could be exactly what you're searching for right now.
$10,000 to each of these companies could deliver major returns over the next decade.
In an expression of disapproval on social media, prominent real estate investor Grant Cardone scrutinized President Joe Biden's proposed hike in capital gains tax in a recent X post. "Biden proposes 44.6% capital gains tax, from current 19%," Cardone posted. "Can't even come up with his own ideas taking a page out of Trudeau playbook who raised Canada to 66%." Cardone then invoked historical political outcomes, writing, "And he ignored how that played out for the last guy who tried it — the enti
There are benefits to investing in stocks that have reasonable multiples and aren't as dependent on future earnings growth to justify their valuations.
Jamie Dimon and Jerome Powell are taking the European viewpoint on soaring debt levels in the U.S.
The JPMorgan Nasdaq Equity Premium Income ETF offers a compelling blend of income and upside to my portfolio.